ACADIA Pharmaceuticals Inc (ACAD)

Total asset turnover

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	US$ in thousands	957,797	726,437	517,235	484,145	441,755
Total assets	US$ in thousands	1,187,760	748,956	587,812	700,122	782,616
Total asset turnover		0.81	0.97	0.88	0.69	0.56

December 31, 2024 calculation

Total asset turnover = Revenue ÷ Total assets
= $957,797K ÷ $1,187,760K
= 0.81

The total asset turnover ratio measures how efficiently a company utilizes its assets to generate revenue. In the case of ACADIA Pharmaceuticals Inc, the total asset turnover has shown an increasing trend over the past five years.

In December 31, 2020, the total asset turnover ratio was 0.56, indicating that for every dollar of total assets, the company generated $0.56 in revenue. By December 31, 2021, the total asset turnover improved to 0.69, showing that the company was becoming more efficient in utilizing its assets to generate revenue.

This upward trend continued in the following years, with the total asset turnover reaching 0.88 by December 31, 2022, and further increasing to 0.97 by December 31, 2023. These figures suggest that ACADIA Pharmaceuticals Inc managed to significantly increase its revenue relative to its total assets, highlighting improved operational efficiency.

However, the total asset turnover ratio dipped slightly to 0.81 by December 31, 2024. Despite this slight decrease, the ratio remains relatively high, indicating that ACADIA Pharmaceuticals Inc continues to effectively leverage its assets to drive revenue generation.

Overall, the increasing trend in ACADIA Pharmaceuticals Inc's total asset turnover reflects the company's ability to efficiently generate revenue from its assets, signaling positive operational performance and effective asset management.